Carmen Barske

Title: Carmen Barske: Innovator in Neurological Therapeutics

Introduction

Carmen Barske, an accomplished inventor based in Loerrach, Germany, has made significant contributions to the field of neurological therapeutics. With a total of four patents to her name, her work primarily focuses on binding molecules and their pharmaceutical applications, particularly for the treatment of diseases affecting the nervous system.

Latest Patents

Carmen's recent inventions showcase her expertise and innovative approach. One of her notable patents is for Nogo-A binding molecules and their pharmaceutical use. This invention emphasizes a binding molecule that effectively interacts with the human NogoA polypeptide, showing a dissociation constant of less than 1000 nM. It includes a polynucleotide encoding this binding molecule, an expression vector, an expression system, and an isolated host cell. These advancements are aimed at providing new treatment methods for diseases of the peripheral (PNS) and central (CNS) nervous systems, including a pharmaceutical composition that incorporates this binding molecule.

Another significant patent is for Antibody (11C7) anti Nogo-A and its pharmaceutical use. This invention pertains to molecules, such as monoclonal antibodies, that bind to the NogoA polypeptide or variants thereof, again demonstrating a dissociation constant of less than 1000 nM. The patent outlines the use of these binding molecules in nerve repair treatments and introduces a pharmaceutical composition for these applications.

Career Highlights

Throughout her career, Carmen has worked with renowned organizations, including Novartis AG and the University of Zurich. These positions have provided her with a platform to engage in groundbreaking research and development in neurological therapies, further establishing her reputation as an innovative leader in her field.

Collaborations

Carmen's journey has also been marked by valuable collaborations with esteemed colleagues such as Martin E. Schwab and Anis Khusro Mir. These partnerships have enriched her research and have facilitated advancements in therapeutic strategies for nervous system-related diseases.

Conclusion

Carmen Barske stands out as a pioneering inventor in the realm of neurological therapeutics. Her commitment to innovation has led to the development of critical binding molecules that hold promise for effective treatments in the field of neuroscience. Through her patents and collaborative efforts, Carmen continues to contribute significantly to improving patient outcomes in the realm of nervous system disorders.